- Filed
- May 7, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 31, 2024 | 308.11M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2024 | $0 |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $20M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $8.42B |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $8.3B |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $1.44B |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $1.69B |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $9.87B |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $8.99B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $2.95B |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $3.27B |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $14.19B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $14.41B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $3.62B |
| Current Assets | Q1 2024 · Dec 31, 2023 | $3.43B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $24.72B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $24.01B |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 307.3M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $638M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $1.13 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $1.13 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $136M |
| Net Income | Q1 2024 · Mar 31, 2023 | $346M |